{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T16:24:09Z","timestamp":1794846249858,"version":"4.9.1"},"reference-count":32,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2008,4,3]],"date-time":"2008-04-03T00:00:00Z","timestamp":1207180800000},"content-version":"vor","delay-in-days":2,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Neurology"],"published-print":{"date-parts":[[2008,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>\n                      Tuberous sclerosis complex (TSC) represents one of the most common genetic causes of epilepsy.\n                      <jats:italic>TSC<\/jats:italic>\n                      gene inactivation leads to hyperactivation of the mammalian target of rapamycin signaling pathway, raising the intriguing possibility that mammalian target of rapamycin inhibitors might be effective in preventing or treating epilepsy in patients with TSC. Mice with conditional inactivation of the\n                      <jats:italic>Tsc1<\/jats:italic>\n                      gene primarily in glia (\n                      <jats:italic>Tsc1<\/jats:italic>\n                      <jats:sup>GFAP<\/jats:sup>\n                      CKO mice) develop glial proliferation, progressive epilepsy, and premature death. Here, we tested whether rapamycin could prevent or reverse epilepsy, as well as other cellular and molecular brain abnormalities in\n                      <jats:italic>Tsc1<\/jats:italic>\n                      <jats:sup>GFAP<\/jats:sup>\n                      CKO mice.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      <jats:italic>Tsc1<\/jats:italic>\n                      <jats:sup>GFAP<\/jats:sup>\n                      CKO mice and littermate control animals were treated with rapamycin or vehicle starting at postnatal day 14 (early treatment) or 6 weeks of age (late treatment), corresponding to times before and after onset of neurological abnormalities in\n                      <jats:italic>Tsc1<\/jats:italic>\n                      <jats:sup>GFAP<\/jats:sup>\n                      CKO mice. Mice were monitored for seizures by serial video\u2010electroencephalogram and for long\u2010term survival. Brains were examined histologically for astrogliosis and neuronal organization. Expression of phospho\u2010S6 and other molecular markers correlating with epileptogenesis was measured by Western blotting.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Early treatment with rapamycin prevented the development of epilepsy and premature death observed in vehicle\u2010treated\n                      <jats:italic>Tsc1<\/jats:italic>\n                      <jats:sup>GFAP<\/jats:sup>\n                      CKO mice. Late treatment with rapamycin suppressed seizures and prolonged survival in\n                      <jats:italic>Tsc1<\/jats:italic>\n                      <jats:sup>GFAP<\/jats:sup>\n                      CKO mice that had already developed epilepsy. Correspondingly, rapamycin inhibited the abnormal activation of the mammalian target of rapamycin pathway, astrogliosis, and neuronal disorganization, and increased brain size in\n                      <jats:italic>Tsc1<\/jats:italic>\n                      <jats:sup>GFAP<\/jats:sup>\n                      CKO mice.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interpretation<\/jats:title>\n                    <jats:p>\n                      Rapamycin has strong efficacy for preventing seizures and prolonging survival in\n                      <jats:italic>Tsc1<\/jats:italic>\n                      <jats:sup>GFAP<\/jats:sup>\n                      CKO mice. Ann Neurol 2008\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/ana.21331","type":"journal-article","created":{"date-parts":[[2008,4,3]],"date-time":"2008-04-03T11:20:21Z","timestamp":1207221621000},"page":"444-453","source":"Crossref","is-referenced-by-count":548,"title":["Rapamycin prevents epilepsy in a mouse model of tuberous sclerosis complex"],"prefix":"10.1002","volume":"63","author":[{"given":"Ling\u2010Hui","family":"Zeng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David H.","family":"Gutmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2008,4,3]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra055323"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2007.01035.x"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1469-1809.2003.00012.x"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.28.6.395"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.60.9.1286"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-8749.2006.tb01302.x"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1038\/ncb847"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1038\/ncb839"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.202476899"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)13044-9"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1203\/01.PDR.0000147727.78571.07"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1002\/gcc.20118"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2006.05.018"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.20784"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.10283"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2007.01110.x"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.10648"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2005.00289.x"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2007.07.015"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2005.11.008"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2006.09.001"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)80657-1"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(01)00333-6"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1101\/gad.901101"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(01)00332-4"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1002\/glia.20036"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2132711100"},{"issue":"8","key":"e_1_2_6_29_2","first-page":"273","article-title":"Characterization of a murine neuronal specific knockout of Tsc1","volume":"46","author":"Meikle LM","year":"2005","journal-title":"Epilepsia"},{"key":"e_1_2_6_30_2","article-title":"Mechanisms of epileptogenesis in tuberous sclerosis complex and related malformations of cortical development with abnormal glioneuronal proliferation","author":"Wong M","journal-title":"Epilepsia"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.2006.03743.x"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.012605299"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2336098100"}],"container-title":["Annals of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fana.21331","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ana.21331","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T14:54:27Z","timestamp":1695912867000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ana.21331"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,4]]}},"alternative-id":["10.1002\/ana.21331"],"URL":"https:\/\/doi.org\/10.1002\/ana.21331","archive":["Portico"],"relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.722951913.793506028","asserted-by":"object"}]},"ISSN":["0364-5134","1531-8249"],"issn-type":[{"value":"0364-5134","type":"print"},{"value":"1531-8249","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,4]]}}}